期刊文献+

咪唑斯汀结合复方甘草酸苷治疗慢性特发性荨麻疹疗效观察 被引量:5

Efficacy of Mizolastine Combined With Compound Glycyrrhizin in the Treatment of Chronic Idiopathic Urticaria
下载PDF
导出
摘要 目的分析研究对慢性特异性荨麻疹患者联合使用咪唑斯汀与复方甘草酸苷治疗的临床效果。方法选我院收治的慢性特异性荨麻疹患者84例作为研究对象。并按照入院时间,将其平分为两组,设为对照组和试验组。对照组患者采用依匹斯汀治疗,试验组患者采用咪唑斯汀联合复方甘草酸苷治疗,对比两组的患者治疗效果。结果试验组患者的治愈率和有效率高于对照组,且试验组患者风团消失的时间快于对照组,且在治疗后1个月的复发次数少于对照组,两组各指标对比,差异具有统计学意义(P<0.05)。结论对慢性特异性荨麻疹患者联合使用咪唑斯汀与复方甘草酸苷进行治疗,可取得较好的治疗效果。 Objective To study the clinical effect of mizolastine combined with compound glycyrrhizin in the treatment of chronic specific urticaria.Methods 84 patients with chronic urticaria in our hospital were selected as the subjects.According to the time of admission,they were divided into two groups,which were set as the control group and the experimental group.The control group was treated with epinastine therapy,the patients in the test group were treated with mizolastine combined with compound glycyrrhizin.The treatment effect was compared between the two groups.Results The cure rate and the effective rate of the patients in the test group were higher than those of the control group.And the test group of patients with wheal disappearing time faster than the control group,the recurrence rate of the 1 month after treatment was less than that of the control group.The difference between the two groups was statistically significant(P<0.05).Conclusion The treatment of combined use of mizolastine and compound glycyrrhizin for patients with chronic specific urticaria can achieve better therapeutic effect.
作者 赵以会 ZHAO Yihui(Department of Dermatology,Feicheng People's Hospital,Feicheng Shandong 271600,China)
出处 《中国继续医学教育》 2018年第12期133-135,共3页 China Continuing Medical Education
关键词 慢性特发性荨麻疹 咪唑斯汀 复方甘草酸苷 chronic idiopathic urticaria mizolastine compound glycyrrhizin
  • 相关文献

二级参考文献35

  • 1张颖.依巴斯汀联合甘草酸二铵治疗慢性特发性荨麻疹临床疗效观察[J].河北医药,2009,31(21):2930-2931. 被引量:1
  • 2张敏,李春阳.Thl-Th2失衡与慢性荨麻疹[J].临床皮肤科杂志,2005,34(5):336-337. 被引量:55
  • 3吴志华.皮肤性病学[M].5版.广州:广东科技出版社,2006:384-385.
  • 4乔刚.咪唑斯汀治疗慢性荨麻疹有效性和安全性评估[J].国外医学:皮肤性病学分册,2001,27(3):180-180.
  • 5Rosenzweig P, Caplain H, Chaufour S, et al. Comparative wheal and flare study of mizolastine vs terfenadine.cetifizine, lomtadine and placebo in healthy volunteers[J]. Br J Clin Pharmacol, 1995, 40(5): 459-465.
  • 6Wedi B, Novacovic V, Koemcer M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitor efleets of anti-inflammatory drugs[J]. J Allergy Clin Immunol, 2000, 105(3): 552-560.
  • 7Carayol N, Crampette L, Mainprice B. et al. Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine[J]. Allergy, 2002, 57:1067-1070.
  • 8Binfeng Lu, Chfistoph E, Zlatko D, et al. Targeted disruption of the interfero-reeeptor 2 gene results in severe immune defects in rniee [J]. Proc Notl Aead Sei USA, 1998, 95(14): 8233-8238.
  • 9Simons FE. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation [J] . Clin Exp Allergy, 1999, 29 Suppl 1: 3-8.
  • 10Kontou-Fili K. Clinical advantages of dual activity in urticaria [J] . Allergy, 2000, 55 Suppl 64: 28-33.

共引文献53

同被引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部